#targeted therapy

14 articles

ALK-Fusion NSCLC

ALK fusion-positive non-small cell lung cancer (NSCLC) is a molecularly defined subtype of lung adenocarcinoma characterized by chromosomal rearrangem...

Mar 18, 2026

Disease

ROS1-Fusion NSCLC

ROS1 fusion-positive non-small cell lung cancer (NSCLC) is a molecularly defined subtype accounting for approximately 1–2% of all NSCLC cases. It aris...

Mar 18, 2026

1 2

AI Medical Advisor

Hello! I'm ChinaMedical AI Assistant. I can help you with information about medical tourism in China, hospital recommendations, treatment costs, medical visas, and more. How can I help you?